256 related articles for article (PubMed ID: 26209226)
1. GTSE1 expression represses apoptotic signaling and confers cisplatin resistance in gastric cancer cells.
Subhash VV; Tan SH; Tan WL; Yeo MS; Xie C; Wong FY; Kiat ZY; Lim R; Yong WP
BMC Cancer; 2015 Jul; 15():550. PubMed ID: 26209226
[TBL] [Abstract][Full Text] [Related]
2. Melanoma associated antigen (MAGE)-A3 promotes cell proliferation and chemotherapeutic drug resistance in gastric cancer.
Xie C; Subhash VV; Datta A; Liem N; Tan SH; Yeo MS; Tan WL; Koh V; Yan FL; Wong FY; Wong WK; So J; Tan IB; Padmanabhan N; Yap CT; Tan P; Goh LK; Yong WP
Cell Oncol (Dordr); 2016 Apr; 39(2):175-86. PubMed ID: 26868260
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of long non-coding RNA PVT1 in gastric cancer cells promotes the development of multidrug resistance.
Zhang XW; Bu P; Liu L; Zhang XZ; Li J
Biochem Biophys Res Commun; 2015 Jul; 462(3):227-32. PubMed ID: 25956062
[TBL] [Abstract][Full Text] [Related]
4. GTSE1 is possibly involved in the DNA damage repair and cisplatin resistance in osteosarcoma.
Xie C; Xiang W; Shen H; Shen J
J Orthop Surg Res; 2021 Dec; 16(1):713. PubMed ID: 34876170
[TBL] [Abstract][Full Text] [Related]
5. HZ08 reverse the aneuploidy-induced cisplatin-resistance in Gastric cancer by modulating the p53 pathway.
Tang X; Hu G; Xu C; Ouyang K; Fang W; Huang W; Zhang J; Li F; Wang K; Qin X; Li Y
Eur J Pharmacol; 2013 Nov; 720(1-3):84-97. PubMed ID: 24183976
[TBL] [Abstract][Full Text] [Related]
6. RhoGDI2 confers gastric cancer cells resistance against cisplatin-induced apoptosis by upregulation of Bcl-2 expression.
Cho HJ; Baek KE; Park SM; Kim IK; Nam IK; Choi YL; Park SH; Im MJ; Choi J; Ryu J; Kim JW; Lee CW; Kang SS; Yoo J
Cancer Lett; 2011 Dec; 311(1):48-56. PubMed ID: 21752536
[TBL] [Abstract][Full Text] [Related]
7. VEGF-C mediates RhoGDI2-induced gastric cancer cell metastasis and cisplatin resistance.
Cho HJ; Kim IK; Park SM; Baek KE; Nam IK; Park SH; Ryu KJ; Choi J; Ryu J; Hong SC; Jeong SH; Lee YJ; Ko GH; Kim J; Won Lee C; Soo Kang S; Yoo J
Int J Cancer; 2014 Oct; 135(7):1553-63. PubMed ID: 24585459
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer.
Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X
FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223
[TBL] [Abstract][Full Text] [Related]
9. Integrated epigenomics identifies BMP4 as a modulator of cisplatin sensitivity in gastric cancer.
Ivanova T; Zouridis H; Wu Y; Cheng LL; Tan IB; Gopalakrishnan V; Ooi CH; Lee J; Qin L; Wu J; Lee M; Rha SY; Huang D; Liem N; Yeoh KG; Yong WP; Teh BT; Tan P
Gut; 2013 Jan; 62(1):22-33. PubMed ID: 22535375
[TBL] [Abstract][Full Text] [Related]
10. Human ether-à-go-go-related gene expression is essential for cisplatin to induce apoptosis in human gastric cancer.
Zhang R; Tian P; Chi Q; Wang J; Wang Y; Sun L; Liu Y; Tian S; Zhang Q
Oncol Rep; 2012 Feb; 27(2):433-40. PubMed ID: 22020779
[TBL] [Abstract][Full Text] [Related]
11. TXNL1 induces apoptosis in cisplatin resistant human gastric cancer cell lines.
Ni P; Xu W; Zhang Y; Chen Q; Li A; Wang S; Xu S; Zhou J
Curr Cancer Drug Targets; 2015; 14(9):850-9. PubMed ID: 25348020
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance.
Yan LH; Wei WY; Cao WL; Zhang XS; Xie YB; Xiao Q
BMC Cancer; 2014 Dec; 14():904. PubMed ID: 25466554
[TBL] [Abstract][Full Text] [Related]
13. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway.
Huang S; Chen M; Ding X; Zhang X; Zou X
Int Immunopharmacol; 2013 Nov; 17(3):585-92. PubMed ID: 23973653
[TBL] [Abstract][Full Text] [Related]
15. [Differential gene expression of the inhibitor of apoptosis proteins in docetaxel-resistant gastric cancer cells].
Wang TT; Wei J; Qian XP; Yu LX; Liu BR
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):573-7. PubMed ID: 19102932
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer.
Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y
Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Inhibition of Apoptosis-Stimulating Protein of p53 (iASPP) Suppresses Cisplatin-Resistant Gastric Carcinoma In Vitro.
Yu J; Li L; Huang C
Med Sci Monit; 2017 Nov; 23():5542-5549. PubMed ID: 29161238
[TBL] [Abstract][Full Text] [Related]
18. Calycosin Enhances Some Chemotherapeutic Drugs Inhibition of Akt Signaling Pathway in Gastric Cells.
Zhou L; Wu Y; Guo Y; Li Y; Li N; Yang Y; Qin X
Cancer Invest; 2017 May; 35(5):289-300. PubMed ID: 28368679
[TBL] [Abstract][Full Text] [Related]
19. Human Helicase RECQL4 Drives Cisplatin Resistance in Gastric Cancer by Activating an AKT-YB1-MDR1 Signaling Pathway.
Mo D; Fang H; Niu K; Liu J; Wu M; Li S; Zhu T; Aleskandarany MA; Arora A; Lobo DN; Madhusudan S; Balajee AS; Chi Z; Zhao Y
Cancer Res; 2016 May; 76(10):3057-66. PubMed ID: 27013200
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological inhibition of DUSP6 suppresses gastric cancer growth and metastasis and overcomes cisplatin resistance.
Wu QN; Liao YF; Lu YX; Wang Y; Lu JH; Zeng ZL; Huang QT; Sheng H; Yun JP; Xie D; Ju HQ; Xu RH
Cancer Lett; 2018 Jan; 412():243-255. PubMed ID: 29050982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
